Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/3/2025

Treatment of Steroid-Induced Enteritis

Initial Management and Route Selection

  • The American Gastroenterological Association recommends switching from oral to intravenous steroids, such as IV methylprednisolone 60 mg every 24 hours or IV hydrocortisone 100 mg four times daily, when bowel edema is present, as oral steroid absorption is significantly impaired 1, 2, 3
  • The standard dosing regimen for IV methylprednisolone is 60 mg every 24 hours, and for IV hydrocortisone is 100 mg four times daily, with higher doses providing no additional benefit and lower doses being less effective 1, 2, 3

Critical Supportive Care

  • The American College of Gastroenterology recommends providing IV fluid and electrolyte replacement with potassium supplementation of at least 60 mmol/day to prevent hypokalemia and hypomagnesemia, which can precipitate toxic dilatation 1, 2
  • Low-molecular-weight heparin is recommended for thromboprophylaxis, as inflammatory bowel disease flares significantly increase thromboembolism risk 2
  • Blood transfusion is recommended to maintain hemoglobin above 8-10 g/dL 2
  • Withdrawal of anticholinergics, antidiarrheals, NSAIDs, and opioids is recommended, as they may precipitate colonic dilatation 2

Day 3 Assessment: The Critical Decision Point

  • Response to IV steroids must be assessed on day 3, with failure indicators including more than 8 bowel movements per day, 3-8 bowel movements per day with C-reactive protein >45 mg/L, presence of mucosal islands or colonic dilatation on abdominal radiography, or deep ulceration on flexible sigmoidoscopy 1, 2

Rescue Therapy for Steroid-Refractory Disease

  • If inadequate response by day 3, initiate rescue therapy immediately with options including infliximab 5 mg/kg IV at weeks 0, 2, and 6, vedolizumab 300 mg IV at weeks 0, 2, and 6, or cyclosporine 2 mg/kg/day IV 1, 2, 4, 5
  • Infliximab and vedolizumab appear equally effective for steroid-refractory enteritis, with the choice based on patient-specific factors such as hematologic malignancies, severe congestive heart failure, or concurrent hepatitis 5
  • For ICI-related enteritis, start with corticosteroids 1-2 mg/kg/day prednisone equivalent for grade 2-3 disease, and add infliximab or vedolizumab if steroid-refractory after 72 hours 6, 7
  • Endoscopy is highly recommended for grade ≥2 to stratify patients for early biologic treatment based on endoscopic features 6, 7

Critical Pitfalls to Avoid

  • Do not continue ineffective IV steroids beyond 7-10 days, as this increases morbidity and mortality associated with delayed surgery 2, 3
  • Only one attempt at rescue therapy should be considered before referral for colectomy, with sequential rescue therapy carrying acceptable short-term outcomes but increasing adverse events 4, 8
  • Early surgical consultation is mandatory, involving colorectal surgery on day of admission, particularly if systemic toxicity, severe abdominal pain, or suspicion of toxic megacolon develops 1, 4, 8

Infection Screening

  • Screen for C. difficile, CMV, and other enteric infections before escalating immunosuppression, and treat C. difficile positive patients with oral vancomycin 500 mg every 6 hours for 10 days while continuing steroids 1, 3